Cell-mediated cytotoxicity to human pulmonary neoplasms

Area of Science:

• Immunology
• Oncology

Background:

• Peripheral blood leukocytes (PBLs) play a crucial role in the host immune response to cancer.
• Understanding the immune system's interaction with tumor cells is vital for developing novel cancer therapies.

Purpose of the Study:

• To investigate the cytotoxic activity of PBLs from patients with pulmonary neoplasia against various cultured cells.
• To determine if this cytotoxicity is specific to lung tumor cells and to assess reactivity against normal lung tissue, fetal lung, and non-lung tumors.

Main Methods:

• Peripheral blood leukocytes were isolated from patients with confirmed pulmonary neoplasia and from age- and sex-matched healthy donors.
• Cytotoxicity assays were performed using cultured cells derived from lung tumors of various histological types, normal adult lung tissue, fetal lung tissue, and tumors of non-pulmonary origin.

Main Results:

• Leukocytes from 73% of lung cancer patients exhibited cytotoxicity against lung tumor-derived cells, significantly higher than against normal adult lung cells (42%) or non-lung tumor cells (18%).
• Reactivity was also observed against fetal lung cells (up to 88% for 13- and 14-week embryos).
• Leukocytes from patients with non-pulmonary tumors or non-malignant conditions showed lower reactivity (35%) against lung tumor cells compared to lung cancer patients.

Conclusions:

• The findings suggest the presence of tumor-specific host immunoreactivity in patients with lung neoplasia.
• The observed cytotoxicity profile indicates a potential immune surveillance mechanism against lung cancer.